Acetylcysteine Solution, USP (Roxane Laboratories, Inc.): Recall - Visible Glass Particle
|
02/03/2012
|
Adcetris (brentuximab vedotin): Drug Safety Communication - Progressive Multifocal Leukoencephalopathy and Pulmonary Toxicity
|
01/13/2012
|
Aliskiren-containing Medications: Drug Safety Comunication - New Warning and Contraindication
|
04/20/2012
|
Ampyra (dalfampridine): Drug Safety Communication - Seizure Risk for Multiple Sclerosis Patients
|
07/23/2012
|
Altuzan (bevacizumab): Counterfeit Product - Contains no Active Ingredient
|
04/03/2012
|
American Regent Injectable Products: Recall - Visible Particulates in Products
|
02/23/2012
|
Argatroban Injection 50 mg/50 mL (1 mg/mL): Recall - Potential for Visible Particulates
|
03/23/2012
|
Avastin (bevacizumab): Counterfeit Product - FDA Issues Letters to 19 Medical Practices
|
02/14/2012
|
Bedford Laboratories Polymyxin B For Injection USP And Vecuronium Bromide For Injection: Recall - Glass Particles
|
01/12/2012
|
Benzalkonium Chloride Antiseptic Wipes by Dukal: Recall - Potential Microbial Contamination
|
08/01/2012
|
Brilliant Blue G Compounded by Franck's: Recall of Unapproved Drug - Ongoing Investigation of Fungal Endophthalmitis Cases
|
04/20/2012
|
CardioGen-82 PET Scan: Drug Safety Communication - Increased Radiation Exposure
|
01/12/2012
|
Celexa (citalopram hydrobromide) - Drug Safety Communication: Revised Recommendations, Potential Risk of Abnormal Heart Rhythms
|
03/28/2012
|
Certain Compounded Drugs from Franck's: FDA Issues Second Warning to Physicians
|
05/04/2012
|
Codeine Use in Certain Children After Tonsillectomy and/or Adenoidectomy: Drug Safety Communication - Risk of Rare, But Life-Threatening Adverse Events or Death
|
08/15/2012
|
Cytarabine for Injection, 1 gm/vial [Bedford Labs]: Recall: Risk of Lack of Sterility
|
02/23/2012
|
Endo Pharmaceuticals Opiate Products by Novartis Consumer Health: Public Health Advisory - Potential Safety Risk
|
01/09/2012
|
Franck’s Compounding Pharmacy Sterile Preparations: Reports of Fungal Endophthalmitis, Expanded Recall
|
05/24/2012
|
Gilenya (fingolimod): Drug Safety Communication - Safety Review of a Reported Death After the First Dose
|
05/14/2012
|
Gris-PEG (griseofulvin ultramicrosize): Health Advisory - Risk of Product Mix-Up
|
02/03/2012
|
H & P Industries Povidone Iodine Prep Pads: Recall - Potential Microbial Contamination
|
02/08/2012
|
Hospira Carpuject Pre-filled Cartridges - Drug Alert: Products May Contain More Than the Intended Fill Volume
|
05/23/2012
|
Hospira Hydromorphone Hydrochloride Injection 2 MG/ML, 1 mL fill in 2.5 mL Carpuject: Recall- May Contain More Than The Intended Fill Volume
|
08/16/2012
|
Hospira Injectable Drug Products: Recall - Visible Particulates from Defective Glass Vials
|
07/16/2012
|
Hospira Lactated Ringer's And 5% Dextrose Injection, 1000 Ml, Flexible Containers: Recall - Mold Contamination
|
10/06/2012
|
Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg (Watson Laboratories): Recall - Potential for Oversized and Superpotent Tablets
|
09/24/2012
|
Hydromorphone Hydrochloride Injection 1 MG/ML, (C-II) 1 ML Fill In 2.5 ML Carpuject: Recall - May Contain More Than the Intended Fill Volume
|
05/14/2012
|
Infants’ TYLENOL Oral Suspension, 1 oz. Grape: Recall - Dosing System Complaints
|
02/17/2012
|
Intestinomicina (contains chloramphenicol) by Laboratorios Lopez: Safety Alert - Contains Drug Ingredient Withdrawn from US
|
09/18/2012
|
Introvale (levonorgestrel and ethinyl estradiol) Tablets: Recall - Packaging Flaw
|
06/06/2012
|
Leucovorin Calcium Injection (Bedford Laboratories): Recall - Visible Particulate Matter
|
07/06/2012
|
Lo/Ovral-28 (Norgestrel/EthinylEstradiol) Tablets: Recall - Possibility of Inexact Tablet Counts or Out of Sequence Tablets
|
02/01/2012
|
Mirapex (pramipexole): Drug Safety Communication - Ongoing Safety Review, Possible Risk of Heart Failure
|
09/19/2012
|
Morphine Sulfate Injection USP, 4 mg/mL (C-II), 1 mL fill in 2.5 mL Carpuject by Hospira, Inc: Recall - May Contain More Than Intended Fill Volume
|
04/18/2012
|
FDA Statement on Fungal Meningitis Outbreak: Additional Patient Notification Advised
|
10/16/2012
|
New England Compounding Center (NECC) Potentially Contaminated Medication: Fungal Meningitis Outbreak
|
10/06/2012
|
Nimodipine: Recall - Crystallization of Fill Material
|
09/05/2012
|
Norgestimate and Ethinyl Estradiol Tablets: Recall - Packaging Error, Potential for Incorrect Dosing Regimen
|
02/27/2012
|
Novartis Consumer Health Over-The-Counter Products: Recall - Potential Presence of Foreign Tablets or Chipped or Broken Tablets or Gelcaps
|
01/09/2012
|
Over-The-Counter Topical Muscle and Joint Pain Relievers: Drug Safety Communication - Rare Cases of Serious Burns
|
09/13/2012
|
Perfect Image Solutions Topical Hair Regrowth Products: Recall - Unapproved Drugs, Risk of Health Hazards
|
01/20/2012
|
Proton Pump Inhibitors (PPIs) - Drug Safety Communication: Clostridium Difficile-Associated Diarrhea (CDAD) Can be Associated With Stomach Acid Drugs
|
02/08/2012
|
Qualitest Hydrocodone Bitartrate and Acetaminophen Tablets 10 mg/500 mg: Recall - Potential for Oversized Tablets
|
09/11/2012
|
Revatio (sildenafil): Drug Safety Communication - Recommendation Against Use in Children
|
08/30/2012
|
Revlimid (lenalidomide): Ongoing Safety Review - Increased Risk of Developing New Malignancies
|
05/07/2012
|
SimplyThick: Public Health Notification - Risk of Life-Threatening Bowel Condition
|
09/18/2012
|
Skin Creams, Soaps and Lotions Marketed as Skin Lighteners and Anti-aging Treatments: May Contain the Toxic Metal, Mercury
|
03/15/2012
|
St. Jude Medical Riata Implantable Cardioverter Defibrillator (ICD) Leads: Safety Communication - Premature Insulation Failure
|
08/16/2012
|
Statins and HIV or Hepatitis C Drugs: Drug Safety Communication - Interaction Increases Risk of Muscle Injury
|
03/01/2012
|
Statin Drugs - Drug Safety Communication: Class Labeling Change
|
02/28/2012
|
Teva’s Adderall 30 mg Tablets: Counterfeit Product - Contains Wrong Active Ingredients
|
05/30/2012
|
Treanda (bendamustine HCL): Recall - Particulate Matter in Vial
|
01/30/2012
|
Tysabri (natalizumab): Drug Safety Communication - New Risk Factor for Progressive Multifocal Leukoencephalopathy (PML)
|
01/20/2012
|
Vecuronium Bromide For Injection Preservative Free (Bedford Laboratories): Recall - Particulate Matter
|
06/29/2012
|
Victrelis (boceprevir) and Ritonavir-Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs: Drug Safety Communication - Drug Interactions
|
04/26/2012
|
Wholistic Herbs, Inc. "Koff and Kold" and "Kold Sore" Spray: Recall - Non-Sterile Products
|
02/10/2012
|